Non-small cell lung cancer stage IIIA

• A randomized phase II study of Pembrolizumab (MK-3475) as maintainance therapy in patients with unresectable stage III non-small cell lung … Pending
  2024-514701-57-01 4 "non Small Cell Lung Cancer"
• A multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacitu … Pending
  2024-517561-16-00 4 "non-small cell lung cancer"
• A clinical study to assess the efficacy of adjuvant immunotherapy with cemiplimab in patients with surgically removed non-small cell lung ca … Recruiting
  2024-519901-36-00 5 2025-12-17 "Patients with resected stage II-IIIA non-small cell lung can"
• A clinical study to investigate the efficacy and safety of an investigational combination therapy with BNT324 and BNT327 in patients with ad … Recruiting
  2024-520238-31-01 9 2026-04-20 "Advanced Lung Cancer"
• A clinical trial to test if an investigational combination therapy with BNT326 and BNT327 is safe and potentially beneficial for people with … Recruiting
  2024-519344-32-00 9 2026-03-16 "Non-small Cell Lung Cancer"
• Safety, efficacy, and pharmacokinetics of BNT327 in combination with chemotherapy and other investigational agents for lung cancer Recruiting
  2024-515764-31-00 10 2025-06-13 "Non-small cell lung cancer"
• A Phase 1 Study Evaluating the Safety, Tolerability, and Efficacy of BL-B01D1 in Subjects with Metastatic or Unresectable Non-Small Cell Lun … Recruiting
  2023-506539-14-00 3 2025-05-27 "Oncology"
• A study to evaluate the benefit of adding durvalumab after chemotherapy, durvalumab and surgery in patients with early-stage, operable, non- … Recruiting
  2023-508773-82-00 5 2025-05-06 "Stage IIB-IIIB (N2) resectable non small cell lung cancer"
• Clinical trial comparing MK-2870 given with pembrolizumab to pembrolizumab alone in participants who have had surgery for NSCLC Recruiting
  2023-508012-35-00 5 2024-10-02 "Newly diagnosed NSCLC with resectable clinical Stage II, III"
• Study of Neoadjuvant and Adjuvant Treatment in Patients with Resectable Non-small Cell Lung Cancer Recruiting
  2023-508852-21-00 4 2022-06-10 "Resectable, Early-stage (II to IIIB) Non-small Cell Lung Can"
• A PHASE 2 STUDY EVALUATING INCB099280 IN PARTICIPANTS WITH SELECT SOLID TUMORS WHO ARE IMMUNE CHECKPOINT INHIBITOR–NAÏVE Ended
  2022-502716-37-00 4 2023-11-27 "Recurrent or advanced/metastatic solid tumors who are immuno"
• A first-in-human clinical trial in adult patients with advanced non-small cell lung cancer of a personalised therapy targeting specific muta … Ended
  2024-513060-26-00 7 2021-04-07 "Non-small cell lung cancer"
• Thoracic Radiotherapy plus Durvalumab in Elderly and/or frail NSCLC stage III patients unfit for chemotherapy - Employing optimized (hypofra … Ended
  2024-513948-28-00 4 2020-05-08 "unresectable stage III NSCLC (Non–small-cell lung cancer)"

Showing 1–13 of 13 trials